Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark…
Dupixent approved in China as the first-ever biologic medicine for patients with COPD Approval follows EU approval of Dupixent for…
NCQA HEDIS-certified CareProminence 360Measures™ technology enhances population health management for health plans and pharmacy benefit managers TAMPA, Fla., Sept. 26,…
PHILADELPHIA, Sept. 26, 2024 /PRNewswire/ -- Alivia Analytics, a leading AI-powered healthcare data analytics and technology company, announced the appointment…
Ashley Blankette joins CAQH to lead product strategy and development for provider and member data solutions that reduce healthcare administrative…
Policy update increases access for millions covered by HCSC BlueCross BlueShield policiesMALVERN, Pa., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics,…
New Business Line Formed to Address Mounting Needs of Medicare Advantage, Medicaid, Home Health, and Senior Living Organizations WASHINGTON, Sept.…
BURLINGTON, Vt., Sept. 23, 2024 /PRNewswire/ -- The Vermont State Dental Society (VSDS), University of Detroit Mercy (UDM), Senator Bernie Sanders,…
BUFFALO, N.Y., Sept. 20, 2024 /PRNewswire/ -- ISI Technology, a leading provider of software solutions for Non-Emergency Medical Transportation (NEMT)…
Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission compared…